Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...
While in the early stages of development, CNTX-0290 gives Lilly a backup in the non-opioid painkiller game should Pfizer-partnered tanezumab fail to be approved for marketing. The NGF inhibitor ...
Will You Look Like an Addict? While it's true that opioid painkillers are one of the most commonly abused prescription drugs, asking for them does not necessarily target you as an addict. Some people ...